GRN and subarachnoid hemorrhage: Besides neurodegenerative diseases, PGRN also acts as a potential therapeutic target for neurological injuries, such as subarachnoid hemorrhage (SAH) [34], acute ischemic stroke [35], and neural injury [20] following spinal contusion.